May 06, 2020
1 min read

Trial investigates estrogen therapy in COVID-19, infection prevention guidance for people with diabetes — top stories in endocrinology

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Data show that men who contract COVID-19 are more likely to be intubated or die compared with women. In light of these findings, researchers launched a trial investigating whether a transdermal estrogen patch can reduce symptom severity compared with regular care among patients with COVID-19. It was the top story in endocrinology last week.

Another top story was about new recommendations endorsed by 50 global organizations on how to reduce the risk for COVID-19 among people with diabetes.

Read these and more top stories in endocrinology below:

Study investigates estrogen patch use to lessen COVID-19 complications

Healio spoke with experts about the role of estrogen in immune response, the sex-based differences in COVID-19 outcomes, and how “crosstalk” across specialties could drive new discoveries in the search for COVID-19 treatments. Read more.

Recommendations for people with diabetes during COVID-19

JDRF and Beyond Type 1 released new guidance for people with diabetes on ways to reduce risk for contracting COVID-19 and curb the spread of disease, with 50 global diabetes organizations endorsing the recommendations, according to a press release. Read more.

Endocrine research spurs synthetic antibody development for COVID-19

A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, are developing a synthetic antibody to SARS-CoV-2, the virus that causes COVID-19. This antibody is intended to block the virus from entering human lung cells, and, if successful in trials, could be a potential treatment option for patients infected with the novel coronavirus. Read more.

Adults with active brown fat show ‘distinct fuel metabolism’ after cold exposure

A small cohort of healthy adults with brown adipose tissue expended 15% more energy after a cold exposure challenge compared with adults who did not have brown adipose tissue, according to findings published in The Journal of Clinical Endocrinology & Metabolism. Read more.

CV outcomes decline, but greater all-cause mortality persists in type 2 diabetes

People with type 2 diabetes are experiencing fewer cardiovascular complications today compared with 1990s data; however, greater all-cause mortality persists among those with diabetes compared with those without the disease, according to a longitudinal analysis of Australian adults published in The Journal of Clinical Endocrinology & Metabolism. Read more.